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Abstract
BACKGROUND: To assess the frequency of normal and abnormal myocardial perfusion imaging (MPI) in a consecutive cohort 
of patients from Pakistan over a period of 8.5 years.
MATERIAL AND METHODS: We assessed 9170 patients who had undergone stress-rest MPI between January 2004 and June 
2013. Patients were assessed for change in demographics, risk factors, and frequency of abnormal and normal MPI.
RESULTS: Overall mean age and male predominance of studied cohort was ≈ 55 years and ≈ 55:45 (M:F), respectively, with 
no appreciable decline or rise. Marked decline in exercise as mode of stress (from 71% to 35%, p value significant) was noted 
during the study period. Regarding the risk factors for CAD, only hypertension was noted to have a significant rising trend 
during the study period. Trend of MPI results over study period was found non-significant from 2004 till 2006 but from 2007 
onward (except 2008), a marginal but significant decline in abnormal MPIs (from 45% to 42%; significant p value) and rise in 
normal MPI (from 55% to 58%; significant p value) was noted.
CONCLUSIONS: We conclude that over the past 8.5 years, a marginal but significant decline in abnormal and a rise in normal 
MPIs trend have been observed. An exorbitant rise in use of vasodilator as a method of stress was also observed. We envis-
aged a follow-up study to ascertain lower negative predictive value of vasodilator as a possible reason and till than results of 
this and other such studies must be read cautiously.
KEY words: myocardial perfusion imaging, temporal trends, negative predictive value, normal MPI, abnormal MPI
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Background
Myocardial perfusion imaging (MPI) using ECG-gated single 
photon emission computerized tomography (GSPECT) since its in-
troduction in late 1980s has become the most commonly performed 
non-invasive functional cardiac imaging modality. This is attributed 
as it provides enormous information for risk assessment of pa-
tients with known or suspected coronary artery disease and aids in 
the assessment of myocardial viability [1]. According to 2010 statis-
tic published by American Heart Association (AHA), there has been 
a progressive decline in cardiac deaths and myocardial infarction, 
yet the burden of disease remain high [2]. A recently published 
single center study from USA has documented a declining trend 
of abnormal GSPECT over a period of two decades [3]. However, 
despite the high death rates due to non-communicable diseases, 
by 2010 the leading cause of death in the developing countries in-
cluding Pakistan would be cardiac deaths [4]. With this diversified 
pattern of cardiac mortalities, the purpose of this study was to as-
sess the frequency of normal and abnormal MPIs in a consecutive 
cohort of patients from Pakistan over a period of 8.5 years.
Material and methods
This study included 10 563 consecutive patients who had 
GSPECT studies at Karachi Institute of Radiotherapy and Nuclear 
Medicine [KIRAN] (3905 patients from January 2004 till Novem-
ber 2009) and Karachi Institute of Heart Diseases [KIHD] (6658 
patients from December 2009 till June 2013). We excluded 1393 
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patients with history of valvular disease and cardiomyopathies, while 
remaining 9170 patients constituted the studied cohort. The study 
was duly approved by ethical review committee of Institutes. As per 
departmental practice, pertinent information regarding demograph-
ics, presenting complaints, risk factors, and history of interven-
tion were recorded. Dynamic exercise (Bruce or Modified Bruce 
Protocol) was used in 4469 patients (48.74%) and remaining 4701 
(51.26%) patients had pharmacological stress using dipyridamole 
(with or without low level exercise). SPECT MPI was acquired using 
one day stress and rest or stress only without gating (3905 pa-
tients from January 2004 till November 2009) and with gating (6658 
patients from December 2009 till June 2013) using 16 frames for 
post-stress studies under dual head gamma cameras (CardioMD, 
Philips, Netherland and Mediso, Hungry till November 2009 and 
only CardioMD, Philips, Netherland from December 2009 onward). 
Technetium-99m labelled Methoxy IsoBbutyl Isonitrile (Tc-99m MIBI) 
in dose of 10–15 mCi (370–555 MBq) for stress and 20–30 mCi 
(740–1110 MBq) for resting studies. Radiotracer was injected at 
least 1 minute before terminating the treadmill stress test and 3 mi-
nutes after dipyridamole infusion (0.142 mg/kg/min for 4 minute). 
We did not use attenuation correction in either study. Left ventricular 
function parameters like ejection fraction (LVEF in %), end-diastolic 
volume (EDV in ml) and end-systolic volume (ESV in ml) were 
measured using commercially available software (Autoquan®). All 
patients were asked to come with 3–4 hour fasting, stop beta and 
calcium blocker 24 hours prior, long acting nitrate and tea/coffee at 
least 12 hour prior the test. All scans were reported by two board 
certified nuclear cardiologists with > 05 years’ experience. 
Statistical analysis
Data was analyzed by using the MedCalc statistical software 
version 11.3.10 and SPSS software version 10. Comparisons be-
tween patient groups were performed using Student’s t test for 
continuous variables and the c2 test for categorical variables. 
Continuous variables were described by mean ± standard de-
viation (SD). Odd ratios with 95% confidence intervals (CIs) were 
calculated. Statistical significance was defined as p < 0.05.
Results
The overall mean age and male predominance of studied 
cohort over the last 8.5 years was ≈ 55 year and ≈ 55:45 (M: F) 
respectively with no appreciable decline or rise. Obesity (BMI > 27) 
was found in 1957 (21.03%) of studied cohort with a significant rise 
during the study period. A significant decline in exercise as mode 
of stress was noted during the study period. Regarding the risk 
factors for CAD, only hypertension was noted to have a significant 
rising trend during the study period, while rest of risk factors did 
not show any significant shift. Incidence of CAD did also show 
a significant declining trend during the study period (Table 1, 
Figure 1). Regarding the trends of MPI results over study period, 
it was found non-significant from 2004 till 2006 but from 2007 on-
ward (except 2008), a marginal but significant decline in abnormal 
MPIs was noted (Table 1 and Figure 2).
Comparing the patients’ cohort with normal and abnormal 
MPI each study year, patients with abnormal MPIs were found 
to be significantly older with male predominance and lower BMI 
Table 1. Patients’ characteristics
Variables 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Total 685 637 690 791 1279 1049 1159 909 1333 638
Age ± SD 55 ± 11 54 ± 10 54 ± 10 53 ± 10 55 ± 11 55 ± 11 55 ± 11 55 ± 10 56 ± 10 56 ± 11
Male 394 358 362 447 753 571 632 505 738 350
Female 291 279 328 344 526 478 527 404 595 288
M:F 58:42 56:44 52:48 57:43 59:41 54:46 55:45 56:44 55:45 55:45
BMI 24.87  
± 5.25
26.32  
± 5.99
26.38  
± 8.53
26.58  
± 7.42
25.75  
± 4.64
26.53  
± 4.97
27.73  
± 9.62
27.98  
± 9.84
27.27  
± 4.93
27.20  
± 4.48
Obese 109 133 135 120 187 195 313 243 365 157
HTN 437 374 419 517 889 718 789 630 972 467
DM 252 207 252 277 500 390 454 357 518 265
Dyslip 207 158 201 252 423 328 401 306 450 231
FH of CAD 224 235 245 280 445 292 371 325 499 221
Smoking 132 118 101 142 200 169 160 145 246 110
CAD 252 177 144 155 288 249 232 201 262 149
Exercise 484 472 448 498 734 553 482 245 332 221
Dipyridamole 201 165 242 293 545 496 677 664 1001 417
METS 7.43 ± 2.39 7.84 ± 4.60 8.01 ± 2.39 8.36 ± 3.87 8.38 ± 5.31 8.45 ± 6.62 8.09 ± 1.98 8.21 ± 5.23 8.88 ± 2.27 7.55 ± 2.19
%THR 84 ± 10 84 ± 11 86 ± 10 86 ± 12 87 ± 10 86 ± 10 86 ± 10 86 ± 10 88 ± 10 87 ± 12
Normal MPI 358 344 365 448 670 581 694 555 776 369
Abnormal MPI 327 293 325 343 609 468 465 354 557 269
%LVEF 58 ± 16 58 ± 18 60 ± 18 59 ± 15 58 ± 16 59 ± 16 59 ± 15 58 ± 15 59 ± 23 58 ± 17
EDV 99 ± 50 101 ± 52 96 ± 49 101 ± 79 101 ± 50 99 ± 51 99 ± 49 98 ± 69 99 ± 52 93 ± 47
ESV 47 ± 44 48 ± 45 45 ± 44 47 ± 44 48 ± 46 45 ± 43 46 ± 44 43 ± 41 45 ± 44 45 ± 40
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(except in 2004 and 2007). Regarding the risk factors, patients with 
abnormal MPIs were found to have significantly higher prevalence 
of diabetes and smoking but significant lower prevalence of hyper-
tension (except in 2006). A non-significant prevalence was found 
for dyslipidemia (except 2005) and family history (except 2004 and 
2010) between patients with normal and abnormal MPIs in each 
study year (Table 2). In patients with normal MPIs, exercise as mode 
of stress shows a significant declining trend, while hypertension, 
diabetes, dyslipidemia, family history, smoking, obesity and CAD 
did not show any significant change in trend over the study period 
(Table 2 and Figure 3). In patients with abnormal MPIs, a signifi-
cant declining trend was noted for exercise as mode of stress and 
presence of CAD, significantly rising trend was observed for diabe-
tes and hypertension, while no significant change in trend was noted 
for rest of attributes (Table 2 and Figure 4). We have also estimated 
odds ratio for predicting an abnormal MPI in studied period, and 
significant odd ratios were estimated for male gender, smoking and 
CAD for abnormal and normal MPI (Table 3).
Discussion
In this study we have observed a mild but significant declining 
trend of abnormal MPIs in the second half of study period. There 
was a concomitant significant increase in mean BMI of all partici-
pants, which is considered to have a positive correlation with CAD 
and associated mortality [5]. However, there are published stud-
ies revealing low incidence of abnormal MPIs in obese patients [6] 
and plausible explanation for this protective role of higher BMI 
is reverse epidemiology and obesity paradox [7]. We have also 
observed an overall significant declining trend of exercise as a mode 
Figure 1. Demographical overall annual incidence trend (%) from 2004 to 2013
Figure 2. Annual incidence trend (%) for normal and abnormal myocardial perfusion imaging (2004 to 2013)
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of stress, and a sedentary life style in studied population could be 
the prime reason for preference towards pharmacological (vaso-
dilator) intervention over exercise as stress method. It is generally 
considered that MPI results obtained with vasodilators stress have 
shown good concordance with exercise stress [8, 9]. However, 
recent studies have shown lower negative predictive value (NPV) 
of a normal MPI done with vasodilator than with dynamic exercise 
[10, 11]. We cannot exclude possible contribution of higher false 
negative results to the rising trend of normal MPIs in our cohort, 
as coronary angiography was not justified in these cases. Our 
results are in concordance with a study published by Rozanski et 
al. [3], although their study exhibited a very steep declining trend 
of abnormal MPIs from 40.9% to 8.7% in 20 years. The primary 
reason could be the larger sample size and longer study duration 
in their study.
Comparing patients with normal and abnormal MPIs on 
yearly basis, older age, male gender predominance, lower BMI, 
diabetes and smoking were found to have significant correlation 
with abnormal than normal MPIs. Except lower BMI, the remaining 
are well established risk factors for CAD and favor contribution 
towards an abnormal MPI. Reverse epidemiology and obesity 
paradox as discussed above may be the possible reasons for 
an unusual association between lower BMI and abnormal MPIs, 
which needs to be explored appropriately. 
Interestingly in patients’ cohort with a marginal rising trend 
of normal MPIs, only dynamic exercise did show an exaggerated 
declining trend while rest of known risk factors did not do exhibit 
any significant change in trend. The possible explanation could 
be the referral bias or possible higher false negative rate (lower 
NPV) of vasodilator stress MPI [12]. While marginal but significant 
declining trend of abnormal MPIs was found to be associated with 
significant rising trend of DM and HTN. This finding is in contra-
diction to previous studies where significant decline in abnormal 
MPIs was associated with reduction in risk factors [3]. One plausible 
Figure 3. Demographical annual %incidence trend from 2004 to 2013 for normal MPI
Figure 4. Demographical annual %incidence trend from 2004 to 2013 for abnormal MPI
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explanation for this finding could be the referral bias and subjecting 
more patients with DM and HTN (mixed population with or without 
symptoms for ischemia) for MPIs studies. Regarding asymptomatic 
diabetics, various prospective studies have shown a lower (6–22%) 
prevalence of ischemia [13]. However, we have not segregated 
patients with or without ischemic symptoms and this is a limitation 
of the study. Another limitation of this study is lack of follow up of 
patients especially those with normal MPIs to find out NPV. The result 
of this study should be read carefully, as marginal but significant 
rise in normal MPI over a period 8.5 years has been associated with 
significantly higher trends of vasodilators stress which has lower 
NPV than exercise. We envisaged following these cases to ascertain 
the NPV of normal MPIs which will be shared in future.
We conclude that over the past 8.5 years, a marginal but sig-
nificant decline in abnormal and a rise in normal MPIs trend have 
been observed. An exorbitant rise in use of vasodilator as method 
of stress has also been observed. We envisaged a follow-up study 
to ascertain lower NPV of vasodilator as a possible reason and till 
than results of this and other such studies must be read cautiously.
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